Nifedipine In Cardiovascular Disorders:
DOI:
https://doi.org/10.47144/phj.v22i2.300Keywords:
Nifedipine In Cardiovascular Disorders,Abstract
Cardiac cellular functions depend on the free cytosolic concentration of Calcium ions. Calcium ions influence the concentration of muscle cells in the myocardium as well as coronary and systemic vessels. The generation and conduction of electric al impulses in the heart is also influenced by intracellular concentration of Calcium ions. This concentration is largely dependent on the movement of Calcium ions from extracellular space into the cell through the surface membrane.By decreasing systemic vascular resistance and arterial pressure, nifedipine causes reflex sympathetic stimulation of the heart. This may increase the left ventricular outflow tract obstruct ion in patients with hypertrophic obstructive cardiomyopathy. The drug may be combined with beta4drenoreceptor blocker to get beneficial results in this situation.In summary, nifedipine is the most widely used calcium antagonist, useful for treatment of all forms of angina pectoris. The drug is also used for treating systemic pulmonary hypertension. By preserving myocardial structure from ischemic changes it may be useful during coronary angioplasty, and it is under investigation for treatment of hypertrophic cardiomyopathy in children.
Downloads
Downloads
How to Cite
Issue
Section
License
When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.
Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/